Laboratoires Pierre Fabre

Laboratoires Pierre Fabre, an international pharmaceutical and dermo-cosmetics group

Laboratoires Pierre Fabre describes itself as an innovative, international French pharmaceutical and dermo-cosmetics group. Its activities cover the research, development and manufacture of medicines and dermo-cosmetic products, with a stated presence in more than 130 territories. The company presents itself as a global healthcare player that combines pharmaceutical and dermo-cosmetic expertise.

Areas of expertise

The group organises its offering into two main areas: dermo-cosmetics and personal care on the one hand, and pharmaceuticals on the other. Within the pharmaceutical area it details therapeutic fields such as oncology, dermatology, chronic diseases, family health, natural healthcare and oral healthcare. The company also mentions a pipeline of oncology projects and business development activities.

In dermo-cosmetics and personal care, the site lists the group's brands, including A-Derma, Ducray, Eau Thermale Avène, Klorane, René Furterer, Elgydium, Elgydium Clinic, Arthrodont, Inava, Darrow, Dexeryl, Eluday, Ladrôme, Laboratoire MÊME and Naturactive.

Research, development and capabilities

The company states that it has in-house capabilities in pharmaceutical innovation, dermo-cosmetic R&D, clinical studies, medical expertise and botanical expertise. These areas are presented as part of its working model for developing new ways to provide care. The group also states that it works with healthcare professionals and with more than one hundred biotech, corporate and laboratory partners worldwide.

Shareholding structure and governance

Laboratoires Pierre Fabre describes a unique shareholding model built around a charitable foundation. Its majority shareholder is the Fondation Pierre Fabre, recognised as a humanitarian foundation of public interest, which receives dividends from the company to improve access to healthcare in developing countries. According to the published figures, the foundation holds 86.3% of the capital, while employees control 9.8% and 80% of the workforce are shareholders. The company maintains a dedicated page on governance, ethics and compliance.

Commitments and areas of action

The group presents a holistic vision of health that covers patients, the environment, regions and employees, and publishes a corporate social responsibility report. Its commitments include pharmaceutical ethics and transparency, with documents on codes and disclosure of payments to healthcare professionals and patient organisations. The company also has the Fondation Pierre Fabre as an affiliated entity.

International presence and contact

The company operates a structure of corporate websites by region and country, with versions for Europe (Belgium, Poland, Denmark, Portugal, Finland, Spain, France, Sweden, Germany, Switzerland, Italy, Turkey and Norway), the Americas (Brazil, Mexico and the United States), Asia (China) and Oceania (Australia). The site offers contact forms segmented by topic, including business development and licensing, information on cosmetic products, information on medicines and other products, finance and accounting, human resources and internships, press, quality complaints, sponsorship and other matters. It also has a dedicated pharmacovigilance form for reporting adverse effects associated with the use of medicines or other products from the laboratories, such as medical devices, food supplements, fortified foods, biocides, substances or cosmetic products.

News and publications

Among the news items featured on the site are World Lymphoma Awareness Day, focused on post-transplant lymphoproliferative disorders (PTLD), the 2025 annual report and the increase in Laboratoires Pierre Fabre's stake in MiYé to accelerate its growth in pharmacies. The company also publishes an annual report and maintains a history section and a careers section under its employer brand We Care Movement.